Roche diagnostics signs supply deal with Nanophase

Roche Diagnostics has signed an agreement with Nanophase to use the firm’s technologies.

Under the terms of the deal, Nanophase will supply Roche with nanoparticles required for research into a medical diagnostics application. Nanophase would not divulge any further information, claiming “material terms of the agreement are confidential”.

Ian Roberts, vice president of sales at Nanophase, said: “We are obviously pleased with this long-term supply agreement with Roche Diagnostics and look forward to growth in the product line and potential new collaboration with Roche,”

“This is yet another product where Nanophase’s innovative technologies produce nanomaterials that offer unique performance attributes for optimal application performance.”

Nanophase supplies a number of industries with nanotechnologies. As well as nanoparticles, it also produces nanoparticle dispersions and custom synthesised particles.

In other news, a nurse looking to get access to controversial cancer drug Herceptin has been told her case cannot be heard until an earlier appeal is completed.

Elisabeth Cooke, 59, had wanted to have her case heard in the High Court but will have to wait for an appeal by Ann Marie Rogers, who lost her bid against the local health authority in February.

© Adfero Ltd